Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 3 days 11 hours 21 mins 28 secs SAVE YOUR SEAT!

Video: APA 2015 – Reaching new heights in targeted quantitation with HRMS

15 Mar 2016
Written by Mark Wrona (Waters Corporation)
Chromatography MS (LC–MS/MS, HRMS, IMS)

https://www.youtube.com/watch?v=62i-2wAEAWgMark Wrona, Senior Science Manager at Waters Corporation, discusses the use of high resolution mass spectrometry (HRMS) for targeted quantitation studies. This presentation was originally given at APA 2015 in Boston (MA, USA).

Top content

  • Bioanalysis Zone announces winner of Rising Star Award 2025
  • Bioanalysis Rising Star Award 2025
  • SCIEX’s ZenoTOF 8600 system acquired by Veloxity Labs

Related tags

HRMS microfluidics
Previous article Next article

Related articles

23 SEP 2024 JOURNAL ARTICLES
Observations from a decade of oligonucleotide bioanalysis by LC–MS
14 OCT 2016 EXPERT OPINION
Quantitative HRMS Press Release – Exploring HRMS: the future is bright
29 OCT 2019 GENERAL INTEREST
Antibody–drug conjugate drug-to-antibody ratio analysis in serum using IA-LC-HRMS
15 OCT 2015 DRUG DEVELOPMENT
Webinar Q&A follow up: ‘The ever-expanding role of HRMS in regulated bioanalysis: application to both small molecule and biopharmaceutical study support’
5 MAY 2016 NEWS
Ultrasensitive microfluidic chip could improve diabetes diagnoses
24 JAN 2018 BIOMARKERS
A highly selective and sensitive LC–MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone